Get started
Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with Amgen Inc.



Key stats


Market capitalization
‪224.48 B‬ USD
Dividend yield (indicated)
2.43%
Price to earnings Ratio (TTM)
25.79
Basic EPS (TTM)
16.22 USD
Net income (FY)
‪7.71 B‬ USD
Revenue (FY)
‪36.74 B‬ USD
Shares float
‪539.36 M‬
Beta (1Y)
0.27

Latest earnings


Last report date
Aug 4, 2026
Report period
Q2 2026
EPS
6.29 USD
Revenue
‪10.05 B‬ USD
Earnings call summary

Q2 2026 revenues rose 10% year-over-year to over $10 billion, driven by strong growth across six key product areas, with 22 products posting double-digit sales gains. Guidance for 2026 was raised, reflecting robust execution, expanding pipeline, and continued investment in innovation.

Employees


Employees (FY)
‪31.5 K‬
Change (1Y)
‪+3.5 K‬+12.50%
Revenue / Employee (1Y)
‪1.17 M‬ USD
Net income / Employee (1Y)
‪244.79 K‬ USD

Company info


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
IPO date
Jun 17, 1983
ISIN
US0311621009
CUSIP
031162100
FIGI
BBG000BBS2Y0
Identifiers
ISIN US0311621009
CFI code
ESVUFR
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


6.387% YTM
Maturity dateMar 2, 2063
Coupon5.75% (Fixed)
6.351% YTM
Maturity dateApr 1, 2097
Coupon8.13% (Fixed)
6.316% YTM
Maturity dateFeb 22, 2062
Coupon4.40% (Fixed)
6.292% YTM
Maturity dateMar 2, 2053
Coupon5.65% (Fixed)
6.268% YTM
Maturity dateFeb 22, 2052
Coupon4.20% (Fixed)
6.267% YTM
Maturity dateJun 15, 2051
Coupon4.66% (Fixed)
6.266% YTM
Maturity dateMar 1, 2053
Coupon4.88% (Fixed)
6.211% YTM
Maturity dateMay 15, 2043
Coupon5.38% (Fixed)
6.207% YTM
Maturity dateSep 1, 2053
Coupon2.77% (Fixed)
6.206% YTM
Maturity dateJun 15, 2048
Coupon4.56% (Fixed)
6.167% YTM
Maturity dateMay 1, 2045
Coupon4.40% (Fixed)

See all AMGN bonds 

ETFs holding the stock


VTI
Vanguard Morningstar Total Stock Market ETF
Weight0.29%
Market value‪6.62 B‬
VOO
Vanguard S&P 500 ETF
Weight0.32%
Market value‪5.46 B‬
SCHD
Schwab US Dividend Equity ETF
Weight4.59%
Market value‪5.00 B‬
QQQ
Invesco QQQ Trust, Series 1
Weight0.97%
Market value‪4.80 B‬
IVV
iShares Core S&P 500 ETF
Weight0.33%
Market value‪3.02 B‬
SPY
SPDR S&P 500 ETF TRUST
Weight0.33%
Market value‪2.75 B‬
DIA
State Street SPDR Dow Jones Industrial Average ETF Trust
Weight4.59%
Market value‪2.15 B‬
VTV
Vanguard Morningstar Value ETF
Weight0.77%
Market value‪1.98 B‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight3.71%
Market value‪1.62 B‬
VIG
Vanguard Div Appreciation ETF
Weight0.90%
Market value‪1.18 B‬
QQQM
Invesco NASDAQ 100 ETF
Weight0.97%
Market value‪1.02 B‬

Explore more ETFs 

Frequently asked questions


The current price of AMGN is 419.38 USD — it has increased by 1.00% in the past 24 hours. Watch Amgen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amgen Inc. stocks are traded under the ticker AMGN.
AMGN stock has risen by 2.67% compared to the previous week, the month change is a 12.14% rise, over the last year Amgen Inc. has showed a 43.61% increase.
We've gathered analysts' opinions on Amgen Inc. future price: according to them, AMGN price has a max estimate of 452.00 USD and a min estimate of 230.00 USD. Watch AMGN chart and read a more detailed Amgen Inc. stock forecast: see what analysts think of Amgen Inc. and suggest that you do with its stocks.
AMGN reached its all-time high on Aug 11, 2026 with the price of 421.79 USD, and its all-time low was 0.08 USD and was reached on Nov 19, 1984. View more price dynamics on AMGN chart.
See other stocks reaching their highest and lowest prices.
AMGN stock is 2.24% volatile and has beta coefficient of 0.27. Track Amgen Inc. stock price on the chart and check out the list of the most volatile stocks — is Amgen Inc. there?
Today Amgen Inc. has the market capitalization of ‪226.73 B‬, it has increased by 7.39% over the last week.
Yes, you can track Amgen Inc. financials in yearly and quarterly reports right on TradingView.
Amgen Inc. is going to release the next earnings report on Nov 3, 2026. Keep track of upcoming events with our Earnings Calendar.
AMGN earnings for the last quarter are 6.29 USD per share, whereas the estimation was 5.62 USD resulting in a 11.97% surprise. The estimated earnings for the next quarter are 5.79 USD per share. See more details about Amgen Inc. earnings.
Amgen Inc. revenue for the last quarter amounts to ‪10.05 B‬ USD, despite the estimated figure of ‪9.43 B‬ USD. In the next quarter, revenue is expected to reach ‪10.04 B‬ USD.
AMGN net income for the last quarter is ‪2.38 B‬ USD, while the quarter before that showed ‪1.82 B‬ USD of net income which accounts for 0.00% change. Track more Amgen Inc. financial stats to get the full picture.
Yes, AMGN dividends are paid quarterly. The last dividend per share was 2.52 USD. As of today, Dividend Yield (TTM)% is 2.34%. Tracking Amgen Inc. dividends might help you take more informed decisions.
Amgen Inc. dividend yield was 2.91% in 2025, and payout ratio reached 66.92%. The year before the numbers were 3.45% and 119.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 18, 2026, the company has ‪31.5 K‬ employees. See our rating of the largest employees — is Amgen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amgen Inc. EBITDA is ‪17.39 B‬ USD, and current EBITDA margin is 43.12%. See more stats in Amgen Inc. financial statements.
Like other stocks, AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amgen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amgen Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amgen Inc. stock shows the strong buy signal. See more of Amgen Inc. technicals for a more comprehensive analysis.